Review
Published on 16 Feb 2022
Gut Microbiota: A Promising Milestone in Enhancing the Efficacy of PD1/PD-L1 Blockade Therapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.847350
- 7,113 views
- 13 citations
Type at least 3 characters
1,279 articles
Articles
Mini Review
Published on 15 Feb 2022
Macrophages and Metabolic Reprograming in the Tumor Microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.795159
- 3,751 views
- 12 citations
Case Report
Published on 14 Feb 2022
Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTEN
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.802074
- 2,264 views
- 4 citations
Original Research
Published on 11 Feb 2022
Elevated Levels of Soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and Systemic Inflammatory Stress as Potential Contributors to Immune Suppression and Generalized Tumorigenesis in a Cohort of South African Xeroderma Pigmentosum Patients
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.819790
- 3,246 views
- 6 citations
Review
Published on 10 Feb 2022
In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.809754
- 36,502 views
- 35 citations
Systematic Review
Published on 09 Feb 2022
Predictive Efficacy of Blood-Based Tumor Mutation Burden Assay for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.795933
- 3,142 views
- 7 citations
Original Research
Published on 08 Feb 2022
Mining GEO and TCGA Database for Immune Microenvironment of Lung Squamous Cell Carcinoma Patients With or Without Chemotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.835225
- 8,223 views
- 6 citations
Case Report
Published on 08 Feb 2022
Case Report: Pathological Complete Response in a Lung Metastasis of Phyllodes Tumor Patient Following Treatment Containing Peptide Neoantigen Nano-Vaccine
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.800484
- 3,891 views
- 6 citations
Review
Published on 07 Feb 2022
Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.809304
- 12,666 views
- 33 citations
Original Research
Published on 02 Feb 2022
Immune Infiltration Associated MAN2B1 Is a Novel Prognostic Biomarker for Glioma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.842973
- 3,335 views
- 3 citations
Review
Published on 02 Feb 2022
Single-Cell Technologies to Decipher the Immune Microenvironment in Myeloid Neoplasms: Perspectives and Opportunities
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.796477
- 5,102 views
Original Research
Published on 27 Jan 2022
Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.823287
- 2,265 views
- 4 citations
Original Research
Published on 26 Jan 2022
PET/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.802257
- 5,306 views
- 17 citations
Review
Published on 25 Jan 2022
TCR-T Immunotherapy: The Challenges and Solutions
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.794183
- 36,370 views
- 48 citations
Review
Published on 25 Jan 2022
(Im)maturity in Tumor Ecosystem
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.813897
- 3,317 views
- 32 citations
Original Research
Published on 24 Jan 2022
An Integrated Pan-Cancer Analysis of 33 Human Cancers Reveals the Potential Clinical Implications and Immunotherapeutic Value of C-X-C Motif Chemokine Ligand 13
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.791962
- 3,134 views
- 3 citations